# An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse

> **NCT01618747** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 20 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01618747
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-15
- **Primary completion:** 2015-12-24
- **Final completion:** 2015-12-24
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01618747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01618747, "An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01618747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*